# Pentoxifylline and Late Onset Sepsis in Preterm Infants

> **NCT02163174** · PHASE3 · COMPLETED · sponsor: **Abd Elazeez Attala Shabaan** · enrollment: 120 (actual)

## Conditions studied

- Neonatal Late Onset Sepsis

## Interventions

- **DRUG:** Pentoxifylline (PTX)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02163174
- **Lead sponsor:** Abd Elazeez Attala Shabaan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163174, "Pentoxifylline and Late Onset Sepsis in Preterm Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02163174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*